[KangPai] Announcement of Board (including Independent Directors) Re-election at 2026 Annual General Meeting

KangPai Biotech held its annual general meeting on May 22, 2026, and completed a comprehensive re-election of its directors and independent directors.
人事NQ 80/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: May 22, 2026 at 09:00
  • 🔍 Collected: May 23, 2026 at 08:00 (23h 0m after Published)
  • 🤖 AI Analyzed: May 24, 2026 at 05:52 (21h 52m after Collected)
1. Date of change: 115/05/22
2. Type of personnel change (legal entity director, legal entity supervisor, independent director, individual director, or individual supervisor): Director and Independent Director
3. Title and name of the predecessor:
(1) Director: Xu Luhui
(2) Director: Ling Yufang
(3) Director: Qiu Quancheng
(4) Director: Zhang Gaorong
(5) Independent Director: Guo Boren
(6) Independent Director: Lin Qingbo
(7) Independent Director: Peng Xianli
4. Resume of the predecessor:
(1) Director Xu Luhui: Chairman and Chief Strategy Officer of KangPai Biotech Co., Ltd.
(2) Director Ling Yufang: CEO and R&D Chief of KangPai Biotech Co., Ltd.
(3) Director Qiu Quancheng: Director of Yidingxing Technology Co., Ltd.
(4) Director Zhang Gaorong: Director of Chisejia Clinic
(5) Independent Director Guo Boren: Financial Manager of Zhongwan Co., Ltd.
(6) Independent Director Lin Qingbo: Distinguished Professor, Institute of Neuroscience, National Yang Ming Chiao Tung University
(7) Independent Director Peng Xianli: Director of Peng Xianli Dermatology Clinic
5. Title and name of the successor:
(1) Director: Xu Luhui
(2) Director: Ling Yufang
(3) Director: Qiu Quancheng
(4) Director: Zhang Gaorong
(5) Independent Director: Lin Qingbo
(6) Independent Director: Luo Baozhu
(7) Independent Director: Peng Xianli
6. Resume of the successor:
(1) Director Xu Luhui: Chairman and Chief Strategy Officer of KangPai Biotech Co., Ltd.
(2) Director Ling Yufang: CEO and R&D Chief of KangPai Biotech Co., Ltd.
(3) Director Qiu Quancheng: Director of Yidingxing Technology Co., Ltd.
(4) Director Zhang Gaorong: Director of Chisejia Clinic
(5) Independent Director Lin Qingbo: Distinguished Professor, Institute of Neuroscience, National Yang Ming Chiao Tung University
(6) Independent Director Luo Baozhu: Independent Director of Everbest Biotech Co., Ltd.; Independent Director of PharmaEngine, Inc.
(7) Independent Director Peng Xianli: Director of Peng Xianli Dermatology Clinic
7. Type of change: Expiration of term
8. Reason for change: Comprehensive re-election due to expiration of term
9. Shareholding at the time of appointment:
(1) Director: Xu Luhui 107,541,980 shares
(2) Director: Ling Yufang 152,297,260 shares
(3) Director: Qiu Quancheng 17,199,060 shares
(4) Director: Zhang Gaorong 17,600,080 shares
(5) Independent Director: Lin Qingbo 29,000 shares
(6) Independent Director: Luo Baozhu 0 shares
(7) Independent Director: Peng Xianli 0 shares
10. Original term: 112/06/29 ~ 115/06/28
11. Effective date of new appointment: 115/05/22
12. Percentage of director changes during the same term: Not applicable (comprehensive re-election).
13. Percentage of independent director changes during the same term: Not applicable (comprehensive re-election).
14. Percentage of supervisor changes during the same term: Not applicable.
15. Whether one-third or more of the directors have changed: No.
16. Other information: None.

FAQ

What is the reason for the board re-election at KangPai Biotech?

It is a comprehensive re-election at the annual general meeting due to the expiration of the board members' terms.

Who is the newly appointed independent director?

Ms. Luo Baozhu has been newly appointed as an independent director.

When does this change take effect?

The change took effect on May 22, 2026, the day of the annual general meeting.